- Home
- ALAR vs ENTX Comparison
ALAR vs ENTX Comparison
Compare ALAR & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- ENTX
- Stock Information
- Founded
- ALAR 2013
- ENTX 2010
- Country
- ALAR Israel
- ENTX Israel
- Employees
- ALAR N/A
- ENTX N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- ENTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ALAR Technology
- ENTX Health Care
- Exchange
- ALAR Nasdaq
- ENTX Nasdaq
- Market Cap
- ALAR 103.6M
- ENTX 106.4M
- IPO Year
- ALAR 2018
- ENTX 2018
- Fundamental
- Price
- ALAR $16.20
- ENTX $2.91
- Analyst Decision
- ALAR Strong Buy
- ENTX Strong Buy
- Analyst Count
- ALAR 1
- ENTX 1
- Target Price
- ALAR $27.00
- ENTX $10.00
- AVG Volume (30 Days)
- ALAR 54.6K
- ENTX 309.2K
- Earning Date
- ALAR 11-24-2025
- ENTX 11-07-2025
- Dividend Yield
- ALAR N/A
- ENTX N/A
- EPS Growth
- ALAR N/A
- ENTX N/A
- EPS
- ALAR 0.07
- ENTX N/A
- Revenue
- ALAR $30,488,000.00
- ENTX $166,000.00
- Revenue This Year
- ALAR $28.77
- ENTX N/A
- Revenue Next Year
- ALAR $31.83
- ENTX N/A
- P/E Ratio
- ALAR $21.22
- ENTX N/A
- Revenue Growth
- ALAR N/A
- ENTX 191.23
- 52 Week Low
- ALAR $5.45
- ENTX $1.50
- 52 Week High
- ALAR $18.00
- ENTX $2.95
- Technical
- Relative Strength Index (RSI)
- ALAR 60.33
- ENTX 70.88
- Support Level
- ALAR $13.50
- ENTX $2.12
- Resistance Level
- ALAR $16.19
- ENTX $2.43
- Average True Range (ATR)
- ALAR 0.79
- ENTX 0.21
- MACD
- ALAR 0.18
- ENTX 0.04
- Stochastic Oscillator
- ALAR 88.23
- ENTX 97.53
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.